Over NIP, MSD and GSK requests for double and single prices respectively

Published: 2016-03-09 15:30:39

Updated: 2016-03-09 15:30:39

While negotiations for cervical cancer vaccines have started among the Korea Center for Disease Control and Prevention(KCDC), MSD and GSK, the two companies were observed to hope double price and single price respectively.

According to the KCDC, Ministry of Health and Welfare, and the pharmaceutical industry, the KCDC has started price negotiations for prices of the cervical cancer vaccines, ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.